Drug Shortage Report for TEVA-MYCOPHENOLATE
Report ID | 107949 |
Drug Identification Number | 02364883 |
Brand name | TEVA-MYCOPHENOLATE |
Common or Proper name | MYCOPHENOLATE 250MG CAPS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MYCOPHENOLATE MOFETIL |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | U/D 100's |
ATC code | L04AA |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-18 |
Estimated end date | 2020-06-30 |
Actual end date | 2020-06-30 |
Shortage status | Resolved |
Updated date | 2020-07-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-06 | English | Compare |